Latest:
COVID-19 Booster Shot Eligibility
Experts discuss who is eligible for COVID-19 booster shots and the misinformation around COVID-19 vaccinations.
© 2022 MJH Life Sciences™ and Contagion Live. All rights reserved.
Authors
Christina H. Mallarino-Haeger, MD
Christina H. Mallarino-Haeger, MD, is an infectious diseases fellow in the Department of Medicine, Division of Infectious Diseases at Emory University School of Medicine in Atlanta, Georgia.
Latest:
Fever of Unknown Origin: What Do We Know and Where Do We Go?
As the number of etiologies increases, we must ground our application of new diagnostic modalities with appropriate assessments.
M. Gabriela Cabanilla, PharmD, PhC
M. Gabriela Cabanilla, PharmD, PhC is an assistant professor at the University of New Mexico College of Pharmacy and an inpatient infectious diseases pharmacist clinician at the University of New Mexico Hospital in Albuquerque, NM. Cabanilla's clinical interests include immunocompromised infectious diseases and optimizing antimicrobial dosing in the critically ill, particularly in ECMO.
Latest:
I Kidney Not: Antibiotic Dosing Strategies in Intermittent Hemodialysis
In the latest article from SIDP, here is a look at the use of various intravenous (IV) antimicrobial therapies to address infections in these patients.
Neelesh Agarwal, PharmD
Neelesh Agarwal PharmD, is a PGY-1 pharmacy resident at Yale-New Haven Hospital, New Haven, Connecticut. He completed his PharmD at Temple University School of Pharmacy in Philadelphia, PA.
Latest:
Discussing Outpatient COVID-19 Treatments
Here is a look at some of the treatment alternatives, which can offer simpler logistics and cost considerations.
Ryan P. McNamara, PhD
Ryan P. McNamara, PhD, is a virologist and research associate at the University of North Carolina at Chapel Hill School of Medicine.
Latest:
Influenza Virus Is Primed for Continual Emergence and Pandemic Potential
The broad host range and natural reassortment of the influenza virus has played an instrumental role in previous pandemics, and the virus is poised for future large-scale outbreaks.